Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome
- PMID: 33548557
- PMCID: PMC8333181
- DOI: 10.1016/j.jvsv.2021.01.017
Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome
Abstract
Objective: We directly compared the Villalta scale and the Venous Clinical Severity Score (VCSS) to determine which of the two measures would be better at capturing clinically important cases of post-thrombotic syndrome (PTS) and PTS severity compared with patient-reported quality of life (QOL) scores.
Methods: We performed a secondary analysis of the ATTRACT (acute venous thrombosis: thrombus removal with adjunctive catheter-directed thrombolysis) trial study population. We calculated the correlations of the Villalta scores and VCSSs with QOL scores (short-form 36-item health survey [SF-36] physical component summary [PCS] and mental component summary [MCS]; and VEINES [venous insufficiency epidemiological and economic study]-QOL/symptom [VEINES-QOL/Sym] questionnaire) at each study visit (6, 12, 18, and 24 months of follow-up). The correlation of the random intercept (mean scores) and random slope (rate of change of the scores) among the Villalta scores, VCSS, and VEINES-QOL/Sym scores was assessed using a multivariate longitudinal model.
Results: The median correlation between Villalta scores and VCSSs was 0.72. The median correlation between the Villalta scores and VEINES-QOL and VEINES-Sym scores at all follow-up visits was -0.68 and -0.71, respectively. The median correlation between the Villalta scores and SF-36 PCS and MCS scores was -0.51 and -0.31, respectively. For the VCSSs, the median correlation with the VEINES-QOL and VEINES-Sym scores at all follow-up visits was -0.39 and -0.41, respectively. The median correlation between the VCSSs and SF-36 PCS and MCS scores was -0.32 and -0.13, respectively. The correlations between the random effects in the multivariate longitudinal models showed a similar pattern. The effect of covariate adjustment by age, sex, and body mass index was minor.
Conclusions: The Villalta scores and VCSSs correlated strongly. The Villalta scale showed a substantially greater correlation with venous disease-specific and general QOL scores compared with the correlation with the VCSS. Our findings suggest that when a single scale is used to assess for clinically meaningful PTS, the Villalta scale will better capture the effects of PTS on patient-reported QOL.
Keywords: Post-thrombotic syndrome; Quality of life; Randomized trial; Venous Clinical Severity Score; Villalta scale.
Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Postthrombotic syndrome and quality of life in patients with iliofemoral venous thrombosis treated with catheter-directed thrombolysis.J Vasc Surg. 2011 Dec;54(6 Suppl):18S-25S. doi: 10.1016/j.jvs.2011.06.021. Epub 2011 Jul 29. J Vasc Surg. 2011. PMID: 21802243
-
Quality of life outcomes for patients undergoing venous stenting for chronic deep venous disease.J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1185-1192.e2. doi: 10.1016/j.jvsv.2021.01.009. Epub 2021 Feb 1. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33540137
-
Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis.Phlebology. 2024 Sep;39(8):550-556. doi: 10.1177/02683555241257868. Epub 2024 May 29. Phlebology. 2024. PMID: 38810108
-
The relation between clinical scores and quality-of-life in long-term follow-up.Phlebology. 2016 Mar;31(1 Suppl):99-105. doi: 10.1177/0268355516631653. Phlebology. 2016. PMID: 26916776 Review.
-
An overview of the most commonly used venous quality of life and clinical outcome measurements.J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):333-40. doi: 10.1016/j.jvsv.2014.09.003. Epub 2014 Oct 23. J Vasc Surg Venous Lymphat Disord. 2015. PMID: 26992316 Review.
Cited by
-
Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial.Circulation. 2025 Mar 25;151(12):835-846. doi: 10.1161/CIRCULATIONAHA.124.073050. Epub 2025 Jan 28. Circulation. 2025. PMID: 39874026 Free PMC article. Clinical Trial.
-
Systematic review of exercise therapy in the management of post-thrombotic syndrome.Phlebology. 2022 Dec;37(10):695-700. doi: 10.1177/02683555221129738. Epub 2022 Sep 26. Phlebology. 2022. PMID: 36164708 Free PMC article.
-
Effect of trimodal pre-rehabilitation on the rehabilitation of patients with gastrointestinal tumors in the perioperative period.Am J Transl Res. 2022 Feb 15;14(2):967-978. eCollection 2022. Am J Transl Res. 2022. PMID: 35273699 Free PMC article.
-
Delphi Consensus on Reporting Standards in Clinical Studies for Endovascular Treatment of Acute Iliofemoral Venous Thrombosis and Chronic Iliofemoral Venous Obstruction.Circ Cardiovasc Interv. 2023 Jul;16(7):e012894. doi: 10.1161/CIRCINTERVENTIONS.123.012894. Epub 2023 Jun 21. Circ Cardiovasc Interv. 2023. PMID: 37340977 Free PMC article. Review.
References
-
- Prandoni P, Kahn SR. Post‐thrombotic syndrome: prevalence, prognostication and need for progress. British Journal of Haematology. 2009;145(3):286–95. - PubMed
-
- Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood. 2018;131(20):2215–22. - PubMed
-
- Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis. 1994;24(suppl 1):158a.
-
- MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. American Journal of Health-System Pharmacy. 2006;63(20_Supplement_6):S5–S15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical